Total Payments
$510.88
2018 Payments
$124.99
Companies
3
Transactions
24
Medicare Patients
2,442
Medicare Billing
$225,276
Payment Breakdown by Category
Food & Beverage$510.88 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $510.88 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $253.63 | 2 | $0 (2018) |
| Allergan Inc. | $132.04 | 21 | $0 (2017) |
| Genentech USA, Inc. | $125.21 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $124.99 | 1 | Biogen, Inc. ($124.99) |
| 2017 | $385.89 | 23 | Allergan Inc. ($132.04) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/01/2018 | Biogen, Inc. | TECFIDERA (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2017 | Genentech USA, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $125.21 | General |
| Category: None | ||||||
| 11/20/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $2.52 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.35 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $2.64 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $1.83 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.87 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $4.39 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $4.03 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2017 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $128.64 | General |
| 01/31/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 567 | 662 | $331,520 | $50,884 |
| 2022 | 9 | 520 | 619 | $297,356 | $45,820 |
| 2021 | 10 | 592 | 737 | $336,250 | $58,577 |
| 2020 | 13 | 763 | 917 | $416,291 | $69,996 |
Total Patients
2,442
Total Services
2,935
Medicare Billing
$225,276
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 162 | $79,500 | $13,509 | 17.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 115 | 122 | $71,980 | $11,480 | 15.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 76 | 98 | $36,260 | $5,796 | 16.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 42 | $36,750 | $5,156 | 14.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 69 | $22,770 | $3,931 | 17.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $19,440 | $2,879 | 14.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 60 | 67 | $26,130 | $2,734 | 10.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $14,490 | $2,471 | 17.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 39 | 40 | $17,200 | $1,683 | 9.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 14 | $7,000 | $1,246 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 138 | 191 | $88,815 | $15,600 | 17.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 51 | 55 | $31,075 | $5,247 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 76 | $23,788 | $4,389 | 18.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 37 | 37 | $25,419 | $4,314 | 17.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 70 | $24,850 | $3,593 | 14.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $18,549 | $2,832 | 15.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $15,030 | $2,304 | 15.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 56 | 56 | $23,520 | $2,139 | 9.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 21 | 24 | $11,160 | $2,035 | 18.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 44 | 46 | $17,480 | $1,896 | 10.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 11 | 19 | $17,670 | $1,469 | 8.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 170 | 265 | $115,275 | $21,324 | 18.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 65 | 67 | $35,845 | $6,823 | 19.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 45 | 45 | $29,025 | $5,468 | 18.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 66 | 100 | $33,000 | $5,436 | 16.5% |
About Dr. Shaik Sayeed, MD
Dr. Shaik Sayeed, MD is a Neurology healthcare provider based in Cudahy, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679651103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shaik Sayeed, MD has received a total of $510.88 in payments from pharmaceutical and medical device companies, with $124.99 received in 2018. These payments were reported across 24 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($510.88).
As a Medicare-enrolled provider, Sayeed has provided services to 2,442 Medicare beneficiaries, totaling 2,935 services with total Medicare billing of $225,276. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Cudahy, WI
- Active Since 11/01/2006
- Last Updated 05/03/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1679651103
Products in Payments
- Non-Covered Product (Drug) $125.21
- TECFIDERA (Drug) $124.99
- NAMZARIC (Drug) $115.44
- VRAYLAR (Drug) $16.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.